Evidence-Based Strategies for Reversing Direct-Acting Oral Anticoagulants

ACPE Activity Number: 0204-0000-21-404-H01-P
Release Date May 12, 2021
Expiration Date: May 13, 2022
Activity Type: Knowledge-based
CE Credits: 1.0 hours (0.1 CEUs)
Activity Fee: Free of charge

Accreditation for Pharmacists

The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Target Audience

This activity was planned to meet the educational needs of pharmacists in hospitals and health systems involved in the management of bleeding associated with the use of direct-acting oral anticoagulant therapy.

Activity Overview

This online interactive resource provides an overview of reversal strategies for direct-acting oral anticoagulants.

Learning Objectives

At the conclusion of this knowledge-based activity, participants should be able to

  • Describe the indications for use, storage, preparation, dosing, and administration of specific pharmacologic reversal agents for direct-acting oral anticoagulants (DOACs).
  • Summarize recent clinical evidence of the safety and efficacy of specific pharmacologic reversal agents for DOACs.
  • Identify authoritative evidence-based protocols and guidelines for using DOAC reversal agents.

More information on this educational activity can be found by clicking below.